ADIPOQ and Insulin resistance: In type II diabetes model mice (KK/Ay mice), oral LPS administration has been shown to improve insulin resistance and glucose intolerance and induce the expression of adiponectin (an anti-inflammatory cytokine) in the adipose tissue [15].